Differentiating intestinal tuberculosis from crohn's disease: A diagnostic challenge

American Journal of Gastroenterology

Volumn 104, Issue 4, 2009, Pages 1003-1012

  Almadi, Majid Abdulrahman ^a   Ghosh, Subrata ^b   Aljebreen, Abdulrahman Mohamed ^c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CLARITHROMYCIN; CLOFAZIMINE; GAMMA INTERFERON; INFLIXIMAB; RIFABUTIN; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANTIBIOTIC THERAPY; ANUS DISEASE; ASCITES; BLOOD ANALYSIS; CAPSULE ENDOSCOPY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DOUBLE BALLOON ENTEROSCOPY; DRUG EFFICACY; DYSENTERY; ENDOSCOPIC BIOPSY; EXTRAPULMONARY TUBERCULOSIS; FEVER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; INTESTINE ENDOSCOPY; INTESTINE PERFORATION; INTESTINE TUBERCULOSIS; LABORATORY TEST; LAPAROSCOPY; LUNG TUBERCULOSIS; META ANALYSIS; MORTALITY; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; PATHOGENESIS; PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RADIODIAGNOSIS; RECTUM HEMORRHAGE; REVIEW; SERODIAGNOSIS; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; TREATMENT RESPONSE; TREND STUDY; TUBERCULIN TEST; TUBERCULOUS PERITONITIS; WEIGHT REDUCTION; INTESTINE MUCOSA; MICROBIOLOGY; TUBERCULOSIS, GASTROINTESTINAL;

CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; INTESTINAL MUCOSA; TUBERCULOSIS, GASTROINTESTINAL;

EID: 65449123539     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2008.162     Document Type: Review

References (99)

1. Marshall JB. Tuberculosis of the gastrointestinal tract and peritoneum. Am J Gastroenterol 1993;88:989-99.
2. Kirsch R, Pentecost M, Hall PM et al. Role of colonoscopic biopsy in distinguishing between Crohn's disease and intestinal tuberculosis. J Clin Pathol 2006;59:840-4.
3. Riedel L, Segal I, Mohamed AE et al. The prolonged course of gastrointestinal tuberculosis. J Clin Gastroenterol 1989;11:671-4.
4. Liu TH. Crohn's disease-differential diagnosis with intestinal tuberculosis (author's transl)]. Zhonghua Nei Ke Za Zhi 1981;20:211-5.
5. Gan HT, Chen YQ, Ouyang Q et al. Differentiation between intestinal tuberculosis and Crohn's disease in endoscopic biopsy specimens by polymerase chain reaction. Am J Gastroenterol 2002;97:1446-51.
6. Isbister WH, Hubler M. Inflammatory bowel disease in Saudi Arabia: presentation and initial management. J Gastroenterol Hepatol 1998;13:1119-24.
7. Abdul-Baki H, ElHajj I,lE Zahabi LM e t al. Clinical epidemiology of inflammatory bowel disease in Lebanon. Inflamm Bowel Dis 2007;13:475-80.
8. Longobardi T, Jacobs P, Wu L et al. Work losses related to inflammatory bowel disease in Canada: results from a National Population Health Survey. Am J Gastroenterol 2003;98:844-9.
9. Longobardi T, Jacobs P, Bernstein CN. Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey. Am J Gastroenterol 2003;98:1064-72.
10. Al Ghamdi AS,Al Mofleh IA,Al Rashed RS et al. Epidemiology and outcome of Crohn's disease in a teaching hospital in Riyadh. World J Gastroenterol 2004;10:1341-4.
11. El Mouzan MI,Abdullah AM,Al Habbal MT. Epidemiology of juvenile-onset inflammatory bowel disease in central Saudi Arabia. J Trop Pediatr 2006;52:69-71.
12. Aghazadeh R,Zali MR, Bahari A et al. Inflammatory bowel disease in Iran:a review of 457 cases. J Gastroenterol Hepatol 2005;20:1691-5.
13. Ouyang Q,Tandon R,Goh KL et al.The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol 2005;21:408-13.
14. Wright JP, Froggatt J,O'Keefe EA et al.The epidemiology of inflammatory bowel disease in Cape Town 1980-1984. S Afr Med J 1986;70:10-5.
15. Armitage E,Drummond H,Ghosh S et al. Incidence of juvenile-onset Crohn's disease in Scotland. Lancet 1999;353:1496-7.
16. Hildebrand H,Finkel Y, Grahnquist L et al. Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001.Gut 2003;52:1432-4.
17. Economou M,Pappas G. New global map of Crohn's disease: genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis 2008;14:709-20.
18. Armitage EL,Aldhous MC,Anderson N et al. Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology 2004;127:1051-7.
19. Shivananda S, Lennard-Jones J, Logan R et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996;39:690-7.
20. Tsironi E, Feakins RM, Probert CS et al. Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom. Am J Gastroenterol 2004;99:1749-55.
21. Montgomery SM, Morris DL, Pounder RE et al. Asian ethnic origin and the risk of inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999;11:543-6.
22. Kipp AM, Stout JE, Hamilton CD et al. Extrapulmonary tuberculosis,human immunodeficiency virus, and foreign birth in North Carolina, 1.BMC Public Health 2008;8:107.
23. Gonzalez OY, Adams G, Teeter LD et al. Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis. Int J Tuberc Lung Dis 2003;7:1178-85.
24. Al Karawi MA, Mohamed AE, Yasawy MI et al. Protean manifestation of gastrointestinal tuberculosis: report on 130 patients. J Clin Gastroenterol 1995;20:225-32.
25. Kasulke RJ, Anderson WJ, Gupta SK et al. Primary tuberculous enterocolitis. Report of three cases and review of the literature. Arch Surg 1981;116:110-3.
26. Patel N ,Amarapurkar D, Agal S et al. Gastrointestinal luminal tuberculosis: establishing the diagnosis. J Gastroenterol Hepatol 2004;19:1240-6.
27. Shah S,Thomas V, Mathan M et al. Colonoscopic study of 50 patients with colonic tuberculosis. Gut 1992;33:347-51.
28. Singh V, Kumar P, Kamal J et al. Clinicocolonoscopic profile of colonic tuberculosis. Am J Gastroenterol 1996;91:565-8.
29. Haddad FS, Ghossain A, Sawaya E et al. Abdominal tuberculosis. Dis Colon Rectum 1987;30:724-35.
30. Chen WS, Su WJ, Wang HS et al. Large bowel tuberculosis and possible influencing factors for surgical prognosis: 30 years' experience. World J Surg 1997;21:500-4.
31. Leung VK, Law ST, Lam CW et al. Intestinal tuberculosis in a regional hospital in Hong Kong: a 10-year experience. Hong Kong Med J 2006;12:264-71.
32. Oostenbrug LE, van Dullemen HM, te Meerman GJ et al. Clinical outcome of Crohn's disease according to the Vienna classification: disease location is a useful predictor of disease course. Eur J Gastroenterol Hepatol 2006;18:255-61.
33. Freeman HJ. Application of the Vienna Classification for Crohn's disease to a single clinician database of 877 patients. Can J Gastroenterol 2001;15:89-93.
34. Dorn SD, Abad JF, Panagopoulos G et al. Clinical characteristics of familial vs. sporadic Crohn's disease using the Vienna Classification. Inflamm Bowel Dis 2004;10:201-6.
35. Palmer KR, Patil DH, Basran GS et al. Abdominal tuberculosis in urban Britain-a common disease. Gut 1985;26:1296-305.
36. Johnson CA, Hill ID, Bowie MD. Abdominal tuberculosis in children. A survey of cases at the Red Cross War Memorial Children's Hospital, 1976-1985. S Afr Med J 1987;72:20-2.
37. Nakamura S, Yanagihara K, Izumikawa K et al. Severe pulmonary tuberculosis complicating ileocecal intussusception due to intestinal tuberculosis: a case report. Ann Clin Microbiol Antimicrob 2008;7:16.
38. Cello JP. Capsule endoscopy features of human immunodeficiency virus and geographical diseases. Gastrointest Endosc Clin N Am 2004;14:169-77.
39. Segal I, Tim LO, Mirwis J et al. Pitfalls in the diagnosis of gastrointestinal tuberculosis. Am J Gastroenterol 1981;75:30-5.
40. Sato S, Yao K, Yao T et al. Colonoscopy in the diagnosis of intestinal tuberculosis in asymptomatic patients. Gastrointest Endosc 2004;59:362-8.
41. Jayanthi V, Robinson RJ, Malathi S et al. Does Crohn's disease need differentiation from tuberculosis? J Gastroenterol Hepatol 1996;11:183-6.
42. Franco-Paredes C, Diaz-Borjon A, Senger MA et al.The ever-expanding association between rheumatologic diseases and tuberculosis. Am J Med 2006;119:470-7.
43. Umapathy KC, Begum R, Ravichandran G et al. Comprehensive findings on clinical, bacteriological, histopathological and therapeutic aspects of cutaneous tuberculosis. Trop Med Int Health 2006;11:1521-8.
44. Amarapurkar DN, Patel ND, Rane PS. Diagnosis of Crohn's disease in India where tuberculosis is widely prevalent. World J Gastroenterol 2008;14:741-6.
45. Epstein D, Watermeyer G, Kirsch R. Review article: the diagnosis and management of Crohn's disease in populations with high-risk rates for tuberculosis. Aliment Pharmacol Ther 2007;25:1373-88.
46. Ghoshal UC, Ghoshal U, Singh H et al. Anti-Saccharomyces cerevisiae antibody is not useful to differentiate between Crohn's disease and intestinal tuberculosis in India. J Postgrad Med 2007;53:166-70.
47. Makharia GK, Sachdev V, Gupta R et al. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis. Dig Dis Sci 2007;52:33-9.
48. Gan H, Ouyang Q, Bu H et al. Value of polymerase chain reaction assay in diagnosis of intestinal tuberculosis and differentiation from Crohn's disease. Chin Med J (Engl) 1995;108:215-20.
49. Amarapurkar DN, Patel ND, Amarapurkar AD et al. Tissue polymerase chain reaction in diagnosis of intestinal tuberculosis and Crohn's disease. J Assoc Physicians India 2004;52:863-7.
50. Li JY, Lo ST, Ng CS. Molecular detection of Mycobacterium tuberculosis in tissues showing granulomatous inflammation without demonstrable acid-fast bacilli. Diagn Mol Pathol 2000;9:67-74.
51. Balamurugan R, Venkataraman S, John KR et al. PCR amplification of the IS6110 insertion element of Mycobacterium tuberculosis in fecal samples from patients with intestinal tuberculosis. J Clin Microbiol 2006;44:1884-6.
52. Pulimood AB, Peter S, Rook GW et al. In situPCR for Mycobacterium tuberculosis in endoscopic mucosal biopsy specimens of intestinal tuberculosis and Crohn disease. Am J Clin Pathol 2008;129:846-51.
53. Al Jahdali H, Memish ZA, Menzies D.The utility and interpretation of tuberculin skin tests in the Middle East. Am J Infect Control 2005;33:151-6.
54. Rangaka MX, Wilkinson KA, Seldon R et al. Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2007;175:514-20.
55. Mazurek GH, Jereb J, Lobue P et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection,United States. MMWR Recomm Rep 2005;54(RR-15):49-55.
56. Manuel O, Kumar D. QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection. Expert Rev Mol Diagn 2008;8:247-56.
57. Franken WP, Timmermans JF, Prins C et al. Comparison of Mantoux and QuantiFERON TB Gold tests for diagnosis of latent tuberculosis infection in Army personnel. Clin Vaccine Immunol 2007;14:477-80.
58. Nsutebu E, Moffitt SJ, Mullarkey C et al. Use of QuantiFERON-TB Gold test in the investigation of unexplained positive tuberculin skin tests. Public Health 2008;122:1284-7.
59. Carvalho AC, Pezzoli MC, El Hamad I et al. QuantiFERON-TB Gold test in the identification of latent tuberculosis infection in immigrants. J Infect 2007;55:164-8.
60. Bocchino M, Matarese A, Bellofiore B et al. Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosisinfection in patient candidates for anti-TNF-alpha treatment. Eur J Clin Microbiol Infect Dis 2008;27:907-13.
61. Bartu V, Havelkova M, Kopecka E. QuantiFERON-TB Gold in the diagnosis of active tuberculosis. J Int Med Res 2008;36:434-7.
62. Caputo D, Alloni R, Garberini A et al. Experience with two cases of intestinal tuberculosis: utility of the QuantiFERON-TB Gold test for diagnosis. Surg Infect (Larchmt) 2008;9:407-10.
63. Itty S, Bakri SJ, Pulido JS et al. Initial results of QuantiFERON-TB Gold testing in patients with uveitis. Eye 2008; published online: 2 May 2008 [e-pub ahead of print].
64. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177-84.
65. Nienhaus A, Schablon A, Diel R Interferon-gamma release assay for the diagnosis of latent TB infection-analysis of discordant results, when compared to the tuberculin skin test. PLoS ONE 2008;3:e2665.
66. Katiyar SK, Sampath A, Bihari S et al. Use of the QuantiFERON-TB Gold In-Tube(R) test to monitor treatment efficacy in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2008;12:1146-52.
67. Ibrahim M, Osoba AO. Abdominal tuberculosis. On-going challenge to gastroenterologists. Saudi Med J 2005;26:274-80.
68. Balthazar EJ, Gordon R, Hulnick D. Ileocecal tuberculosis: CT and radiologic evaluation. AJR Am J Roentgenol 1990;154:499-503.
69. Boudiaf M, Zidi SH, Soyer P et al. Tuberculous colitis mimicking Crohn's disease: utility of computed tomography in the differentiation. Eur Radiol 1998;8:1221-3.
70. Makanjuola D. Is it Crohn's disease or intestinal tuberculosis? CT analysis. Eur J Radiol 1998;28:55-61.
71. Sinan T, Sheikh M, Ramadan S et al. CT features in abdominal tuberculosis: 20 years experience. BMC Med Imaging 2002;2:3.
72. Kim KW, Ha HK. MRI for small bowel diseases. Semin Ultrasound CT MR 2003;24:387-402.
73. Papadakis KA, Tabibzadeh S. Diagnosis and misdiagnosis of inflammatory bowel disease. Gastrointest Endosc Clin N Am 2002;12:433-49.
74. Bhargava DK, Kushwaha AK, Dasarathy S et al. Endoscopic diagnosis of segmental colonic tuberculosis. Gastrointest Endosc 1992;38:571-4.
75. Naga MI, Okasha HH, Ismail Z et al. Endoscopic diagnosis of colonic tuberculosis. Gastrointest Endosc 2001;53:789-93.
76. Leung VK, Tang WL, Cheung CH et al. Importance of ileoscopy during colonoscopy for the early diagnosis of ileal tuberculosis: report of two cases. Gastrointest Endosc 2001;53:813-5.
77. Alvares JF, Devarbhavi H, Makhija P et al. Clinical, colonoscopic, and histological profile of colonic tuberculosis in a tertiary hospital. Endoscopy 2005;37:351-6.
78. Bhargava DK, Tandon HD, Chawla TC et al. Diagnosis of ileocecal and colonic tuberculosis by colonoscopy. Gastrointest Endosc 1985;31:68-70.
79. Kalvaria I, Kottler RE, Marks IN.The role of colonoscopy in the diagnosis of tuberculosis. J Clin Gastroenterol 1988;10:516-23.
80. Pettengell KE, Pirie D, Simjee AE. Colonoscopic features of early intestinal tuberculosis. Report of 11 cases. S Afr Med J 1991;79:279-80.
81. Ferentzi CV, Sieck JO, Ali MA. Colonoscopic diagnosis and medical treatment of ten patients with colonic tuberculosis. Endoscopy 1988;20:62-5.
82. Bhansali SK. Abdominal tuberculosis. Experiences with 300 cases. Am J Gastroenterol 1977;67:324-37.
83. Lee YJ, Yang SK, Byeon JS et al. Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn's disease. Endoscopy 2006;38:592-7.
84. Rai S,Thomas WM. Diagnosis of abdominal tuberculosis: the importance of laparoscopy. J R Soc Med 2003;96:586-8.
85. Nakamura M, Niwa Y, Ohmiya N et al. Small bowel tuberculosis diagnosed by the combination of video capsule endoscopy and double balloon enteroscopy. Eur J Gastroenterol Hepatol 2007;19:595-8.
86. Yeh TS, Liu KH, Su MY et al. Laparoscopically assisted bowel surgery in an era of double-balloon enteroscopy: from inside to outside. Surg Endosc 2008; published online: 12 July 2008 [e-pub ahead of print].
87. Pulimood AB, Ramakrishna BS, Kurian G et al. Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn's disease from tuberculosis. Gut 1999;45:537-41.
88. Abubakar I, Myhill D, Aliyu SH et al. Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and meta-analysis. Inflamm Bowel Dis 2008;14:401-10.
89. Selby W, Pavli P, Crotty B et al. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology 2007;132:2313-9.
90. Lipton JE, Barash DP. Flawed Australian CD study does not end MAP controversy. Gastroenterology 2007;133:1742-6.
91. Kuenstner JT. The Australian antibiotic trial in Crohn's disease: alternative conclusions from the same study. Gastroenterology 2007;133:1742-3.
92. Gitlin L, Biesecker J. Australian Crohn's antibiotic study opens new horizons. Gastroenterology 2007;133:1743-4.
93. Chamberlin W. Importance of the Australian Crohn's disease antibiotic study. Gastroenterology 2007;133:1744-5.
94. Velayos FS, Sandborn WJ. Positioning biologic therapy for Crohn's disease and ulcerative colitis. Curr Gastroenterol Rep 2007;9:521-7.
95. Raval A, Akhavan-Toyserkani G, Brinker A et al. Brief communication: characteristics of spontaneous cases of tuberculosis associated with infliximab. Ann Intern Med 2007;147:699-702.
96. Baldin B, Dozol A, Spreux A et al. Tuberculosis and infliximab treatment. National surveillance from January 1, 2000, through June 30,2003. Presse Med 2005;34:353-7.
97. Keane J, Gershon S, Wise RP et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-104.
98. Theis VS, Rhodes JM. Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease. Aliment Pharmacol Ther 2008;27:19-30.
99. Das K, Ghoshal UC, Dhali GK et al. Crohn's disease in India: a multi-center study from a country where tuberculosis is endemic. Dig Dis Sci 2008.